The cost-effectiveness of typhoid Vi vaccination programs: Calculations for four urban sites in four Asian countries

被引:51
作者
Cook, Joseph [1 ]
Jeuland, Marc [2 ]
Whittington, Dale [2 ,3 ]
Poulos, Christine [4 ]
Clemens, John [5 ]
Sur, Dipika [6 ]
Anh, Dang Duc [7 ]
Agtini, Magdarina [8 ]
Bhutta, Zulfiqar [9 ]
机构
[1] Univ Washington, Evans Sch Publ Affairs, Seattle, WA 98195 USA
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Manchester Business Sch, Manchester M15 6PB, Lancs, England
[4] RTI Int, Res Triangle Pk, NC USA
[5] Int Vaccine Inst, Seoul, South Korea
[6] Natl Inst Cholera & Enter Dis, Kolkata, India
[7] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam
[8] Natl Inst Hlth Res & Dev, Jakarta, Indonesia
[9] Aga Khan Univ, Dept Paediat, Karachi, Pakistan
关键词
Typhoid vaccination; Cost-effectiveness; Asia;
D O I
10.1016/j.vaccine.2008.09.040
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The burden of typhoid fever remains high in impoverished settings, and increasing antibiotic resistance is making treatment costly. One strategy for reducing the typhoid morbidity and mortality is vaccination with the Vi polysaccharide vaccine. We use a wealth of new economic and epidemiological data to evaluate the cost-effectiveness of Vi vaccination against typhoid in sites in four Asian cities: Kolkata (India), Karachi (Pakistan), North Jakarta (Indonesia), and Hue (Vietnam). We report results from both a societal as well as a public sector financial perspective. Baseline disease burden estimates in the four areas are: 750 cases per year in two Kolkata neighborhoods (pop 185,000); 84 cases per year in the city of Hue (pop 280,000); 298 cases per year in two sub-districts in North Jakarta (pop 161,000), and 538 cases per year in three squatter settlements in Karachi (pop 102,000). We estimate that a vaccination program targeting all children (2-14.9) would prevent 456, 158, and 258 typhoid cases (and 4.6, 1.6, and 2.6 deaths), and avert 126, 44, and 72 disability-adjusted life years (DALYs) over 3 years in Kolkata, North Jakarta and Karachi, respectively. The net social costs would be US$160 and US$549, per DALY averted in Kolkata and North Jakarta, respectively. These programs, along with a similar program in Karachi, would be considered "very cost-effective" (e.g. costs per DALY averted less than per capita gross national income (GNI)) under a wide range of assumptions. Community-based vaccination programs that also target adults in Kolkata and Jakarta are less cost-effective because incidence is lower in adults than children, but are also likely to be "very cost-effective". A program targeting school-aged children in Hue, Vietnam would prevent 21 cases, avert 6 DALYs, and not be cost-effective (US$3779 per DALY averted) because of the low typhoid incidence there. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6305 / 6316
页数:12
相关论文
共 36 条
[1]   PREVENTION OF TYPHOID-FEVER IN NEPAL WITH THE VI CAPSULAR POLYSACCHARIDE OF SALMONELLA-TYPHI - A PRELIMINARY-REPORT [J].
ACHARYA, IL ;
LOWE, CU ;
THAPA, R ;
GURUBACHARYA, VL ;
SHRESTHA, MB ;
CADOZ, M ;
SCHULZ, D ;
ARMAND, J ;
BRYLA, DA ;
TROLLFORS, B ;
CRAMTON, T ;
SCHNEERSON, R ;
ROBBINS, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (18) :1101-1104
[2]   Vaccines against cholera, typhoid fever and shigellosis for developing countries [J].
Acosta, CJ ;
Galindo, CM ;
Deen, JL ;
Ochiai, RL ;
Lee, HJ ;
von Seidlein, L ;
Carbis, R ;
Clemens, JD .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (12) :1939-1951
[3]  
[Anonymous], GUID PREP PROP GAVI
[4]  
Bahl R, 2004, J HEALTH POPUL NUTR, V22, P304
[5]   Household demand for typhoid fever vaccines in Hue, Vietnam [J].
Canh, DG ;
Whittington, D ;
Thoa, LTK ;
Utomo, N ;
Hoa, NT ;
Poulos, C ;
Thuy, DTD ;
Kim, D ;
Nyamete, A ;
Acosta, C .
HEALTH POLICY AND PLANNING, 2006, 21 (03) :241-255
[6]   Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children [J].
Canh, DG ;
Lin, FY ;
Thiem, VD ;
Trach, DD ;
Trong, ND ;
Mao, ND ;
Hunt, S ;
Schneerson, R ;
Robbins, JB ;
Chu, CY ;
Shiloach, J ;
Bryla, DA ;
Bonnet, MC ;
Schulz, D ;
Szu, SC .
INFECTION AND IMMUNITY, 2004, 72 (11) :6586-6588
[7]   Reliability of stated preferences for cholera and typhoid vaccines with time to think in Hue, Vietnam [J].
Cook, Joseph ;
Whittington, Dale ;
Canh, Do Gia ;
Johnson, F. Reed ;
Nyamete, Andrew .
ECONOMIC INQUIRY, 2007, 45 (01) :100-114
[8]  
Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346
[9]   Typhoid fever and childhood vaccine strategies [J].
Griffin, GE .
LANCET, 1999, 354 (9180) :698-699
[10]   Experience with Salmonella typhi Vi capsular polysaccharide vaccine [J].
Hessel, L ;
Debois, H ;
Fletcher, M ;
Dumas, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (09) :609-620